Abstract
Butyrate is a microbial metabolite with pleiotropic effects. Schulthess et al. (2019) report that butyrate preconditioning of macrophages enhances their anti-bacterial preparedness by inducing anti-microbial proteins that restrict bacterial growth. This study augments understanding of how microbial metabolites shape host defense.
| Original language | English |
|---|---|
| Pages (from-to) | 275-278 |
| Number of pages | 4 |
| Journal | Immunity |
| Volume | 50 |
| Issue number | 2 |
| DOIs | |
| State | Published - 19 Feb 2019 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2019 Elsevier Inc.
Funding
W.S.G. is a member of the SABs of Kintai Therapeutics, Evelo Biosciences, and Leap Therapeutics. She has consulted for Pfizer Consumer Health, Merck, Celgene, and BiomX in the past two years.
| Funders |
|---|
| BiomX |
| Evelo Biosciences |
| Kintai Therapeutics |
| Pfizer Consumer Health |
| Merck |
| Celgene |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Butyrate Makes Macrophages “Go Nuclear” against Bacterial Pathogens'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver